In the rapidly advancing fields of gastroenterology and inflammatory research, scientists are increasingly focused on identifying targeted compounds that can suppress hyper-inflammatory pathways without causing systemic immunosuppression. Among these compounds, the tripeptide KPV has emerged as a highly promising molecule for studying localized inflammation, particularly within the gastrointestinal tract and dermatological models. For biomedical researchers […]
